Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Rallybio (RLYB) EBITDA Margin (2024 - 2025)

Rallybio (RLYB) has disclosed EBITDA Margin for 2 consecutive years, with 2638.74% as the latest value for Q4 2025.

  • Quarterly EBITDA Margin rose 2669021.0% to 2638.74% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 1052.21% through Dec 2025, up 802357.0% year-over-year, with the annual reading at 1052.21% for FY2025, 802357.0% up from the prior year.
  • EBITDA Margin hit 2638.74% in Q4 2025 for Rallybio, down from 7558.02% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 7558.02% in Q3 2025 to a low of 29328.95% in Q4 2024.